Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Long-Term Follow-Up Study in Participants Who Previously Participated in a Gamgertamig (OM336) Parent Clinical Study

NCT07847892 is registered in ClinicalTrials.gov with Lakefront Biotherapeutics West LLC as lead sponsor.

NCT NCT07847892
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07847892 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Long-Term Follow-Up Study in Participants Who Previously Participated in a Gamgertamig (OM336) Parent Clinical Study
Lead sponsor
Lakefront Biotherapeutics West LLC
Phase
Observational
Overall status
Not yet recruiting
Start date
October 31, 2026
Completion date
December 31, 2029
Enrollment
100 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

autoimmune cytopenias